Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Descovy

Active ingredient: Emtricitabine Tenofovir Alafenamide

Neutral reference profile for an independent medicine-access consultancy enquiry about Descovy (Emtricitabine Tenofovir Alafenamide). No medicine is offered for sale.

NEXT STEP

Choose the strength and pack

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

ABOUT THIS MEDICINE

What is Descovy used for?

Descovy (emtricitabine/tenofovir alafenamide) is indicated for the treatment of individuals infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immunodeficiency syndrome (AIDS). It is used in adults and adolescents aged over 12 years and who weigh at least 35 kg.

This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.

RECORDED PRODUCT PROFILE

Descovy identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordDescovy
Active ingredientEmtricitabine Tenofovir Alafenamide
Dosage formfilm-coated tablets
Recorded options6
Directory areaInfectiology
Catalogue synchronised

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

  1. 200 mg/10 mg · 30 tablets Catalogue organisation: Gilead Sciences GmbH
  2. 200 mg/10 mg · 60 tablets Catalogue organisation: Gilead Sciences GmbH
  3. 200 mg/10 mg · 90 tablets Catalogue organisation: Gilead Sciences GmbH
  4. 200 mg/25 mg · 30 tablets Catalogue organisation: Gilead Sciences GmbH
  5. 200 mg/25 mg · 60 tablets Catalogue organisation: Gilead Sciences GmbH
  6. 200 mg/25 mg · 90 tablets Catalogue organisation: Gilead Sciences GmbH

OFFICIAL SOURCES

Check the Descovy record at an official source.

Search for “Descovy” or “Emtricitabine Tenofovir Alafenamide”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.

SERVICE BOUNDARY

Information checking and independent enquiry support for Descovy.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Descovy

01What is Descovy?

This directory record associates the brand name Descovy with the active ingredient Emtricitabine Tenofovir Alafenamide. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Descovy strengths and packs are recorded?

The catalogue currently shows: 200 mg/10 mg · 30 tablets; 200 mg/10 mg · 60 tablets; 200 mg/10 mg · 90 tablets; 200 mg/25 mg · 30 tablets. Check the complete strength, dosage form and pack description against the prescription and medicine box.

03Who manufactures Descovy?

Catalogue records currently name: Gilead Sciences GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Descovy?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Descovy, payment request, stock guarantee or binding offer.

06Can I buy Descovy from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.